Episode 180: A RELYable ARISTOTELian look at ROCKET science
In episode 180, Mike and James invite Mike Kolber back to go over the three major trials that have compared warfarin to the new oral anticoagulants. We try, with limited success, to put all the science into perspective. At the end of the podcast, against all odds, we each have a stroke and a major bleed at the same time which dampens our recommendations.
Show notes
1) Tools for Practice
Novel Oral Anti-coagulants (NOACs): is newer better?
2) peterloewen.com for stroke risk and benefit calculator
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
